Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seismic energy from small earthquakes maps fault segmentation in the Southeastern Alps.

Scientific reports·2026
Same author

Modelling intestinal glucose absorption in premature infants using continuous glucose monitoring data.

Computer methods and programs in biomedicine·2018
Same author

Executive summary and conclusions from the European Hydration Institute Expert Conference on human hydration, health, and performance.

Nutrition reviews·2015
Same author

Methylphenidate decreases fat and carbohydrate intake in obese teenagers.

Obesity (Silver Spring, Md.)·2013
Same author

Urinary tract infections in children: a review.

Minerva pediatrica·2012
Same author

Genetic risk for recurrent urinary tract infections in humans: a systematic review.

Journal of biomedicine & biotechnology·2010

Related Experiment Video

Updated: May 19, 2026

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
11:59

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus

Published on: April 28, 2023

Vasoactive compounds in the neonatal period.

P Toth-Heyn1, L Cataldi

  • 11st Department of Pediatrics, Pediatric Intensive Care Unit, Semmelweis University, Bokay J. U. 53, 1083 Budapest, Hungary. toth-heyn.peter@med.semmelweisuniv.hu

Current Medicinal Chemistry
|August 11, 2012
PubMed
Summary

Maintaining stable blood pressure in preterm infants is crucial to prevent serious complications. Neonatal hemodynamics differ from adults, requiring careful consideration of vasoactive agent use and advanced diagnostics.

More Related Videos

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
08:02

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 19, 2013

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Related Experiment Videos

Last Updated: May 19, 2026

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
11:59

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus

Published on: April 28, 2023

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
08:02

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 19, 2013

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Area of Science:

  • Neonatal Physiology
  • Pediatric Cardiology
  • Pharmacology

Background:

  • Newborns, especially preterm infants, have unique hemodynamic regulation.
  • Systemic hypotension in neonates can lead to critical organ hypoperfusion.
  • Standard adult hemodynamic management principles are not directly applicable to neonates.

Purpose of the Study:

  • To highlight the importance of stable blood pressure in preterm infants.
  • To discuss the unique hemodynamic challenges in neonatal care.
  • To review the appropriate use of vasoactive agents in neonates.

Main Methods:

  • Review of existing literature on neonatal hemodynamics and vasoactive drug use.
  • Discussion of differences between adult and neonatal cardiovascular regulation.
  • Emphasis on diagnostic tools for differentiating hypotension and hypoperfusion.

Main Results:

  • Neonatal hemodynamics are distinct due to developmental changes in catecholamine sensitivity and myocardial structure.
  • Commonly used catecholamines (dopamine, epinephrine, dobutamine) require careful administration and monitoring of systemic and cerebral blood flow.
  • Newer vasoactive agents need thorough evaluation for neonatal application.

Conclusions:

  • Careful consideration of neonatal physiology is essential when managing hypotension.
  • Advanced diagnostics are necessary to guide appropriate vasoactive medication selection.
  • Further research, including preclinical and human studies, is needed for newer agents.